Definitive Healthcare (NASDAQ:DH) Updates FY24 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $0.36-$0.38 for the period, compared to the consensus earnings per share estimate of $0.38. The company issued revenue guidance of $255-261 million, compared to the consensus revenue estimate of $266.31 million. Definitive Healthcare also updated its Q2 guidance to $0.08-$0.09 EPS.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on the company. Stifel Nicolaus decreased their price target on Definitive Healthcare from $12.00 to $11.00 and set a buy rating for the company in a research note on Wednesday, January 17th. Needham & Company LLC lowered shares of Definitive Healthcare from a buy rating to a hold rating in a research note on Wednesday, January 17th. Barclays raised their price target on shares of Definitive Healthcare from $10.00 to $11.00 and gave the stock an equal weight rating in a research note on Friday, March 1st. Finally, Canaccord Genuity Group upped their target price on shares of Definitive Healthcare from $9.00 to $10.00 and gave the stock a hold rating in a research note on Thursday, February 29th. Seven investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of Hold and a consensus target price of $11.31.

Definitive Healthcare Stock Down 1.2 %

NASDAQ:DH traded down $0.09 during midday trading on Tuesday, reaching $7.25. 480,881 shares of the stock traded hands, compared to its average volume of 560,899. The stock has a market capitalization of $853.98 million, a PE ratio of -4.07, a price-to-earnings-growth ratio of 6.12 and a beta of 1.41. Definitive Healthcare has a 12-month low of $5.53 and a 12-month high of $12.45. The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.31 and a current ratio of 2.31. The business has a 50-day moving average of $7.82 and a two-hundred day moving average of $8.31.

Definitive Healthcare (NASDAQ:DH) last issued its quarterly earnings results on Wednesday, February 28th. The company reported ($0.01) EPS for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). Definitive Healthcare had a positive return on equity of 0.43% and a negative net margin of 80.40%. The firm had revenue of $65.93 million for the quarter, compared to analyst estimates of $66.01 million. On average, equities analysts forecast that Definitive Healthcare will post 0.11 earnings per share for the current fiscal year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.